Table 2.
Atrial conduction times before and after the administration of antazoline expressed in ms
| Baseline | Antazoline | P | |
|---|---|---|---|
| HRA–proximal CS (CS 9/10) | 111.4 ± 20.9 | 115.7 ± 25.5 | .1559 |
| HRA–proximal CS (CS 9/10) refa | 159.0 ± 43.3 | 179.4 ± 35.5 | .1526 |
| Proximal CS (CS 9/10)– LSPV | 4.21 ± 19.6 | 6.43 ± 26.2 | .6437 |
| Proximal CS (CS 9/10) – LSPV refa | 13.0 ± 35.6 | 1.5 ± 26.6 | .2282 |
| Distal CS (CS 1/2)– LSPV | −24.2 ± 20.1 | −27.7 ± 19.8 | .3349 |
| Distal CS (CS 1/2) ‐ LSPV refa | −33.7 ± 28.4 | −40.1 ± 18.2 | .2407 |
CS, coronary sinus; HRA, high right atrium; LSPV, left superior pulmonary vein.
a
measured 10 ms above the right atrium effective refractory period (RA ERP).